AMRX Earnings — Amneal Pharmaceuticals, Inc. Class A Common Stock Post-ER Performance | BigEarnings
AMRX — Amneal Pharmaceuticals, Inc. Class A Common Stock
XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Price$13.17
Market Cap$4.2B
P/E34.4
52W Range$7.07 – $15.42
Next Earnings2026-08-04
About Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
